Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer

Volume: 122, Pages: 200 - 205
Published: Aug 1, 2018
Abstract
Zoledronate (ZOL) is usually used for prevention of skeletal-related events in cancer patients with bone metastases. The first administration of ZOL is occasionally associated with development of acute-phase reaction (APR), which is due to activation of γδ T cells. ZOL-related APR was associated with better overall survival (OS) of patients with non-small cell lung cancer (NSCLC) in our previous retrospective study. However, it remains to be...
Paper Details
Title
Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer
Published Date
Aug 1, 2018
Volume
122
Pages
200 - 205
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.